[225Ac]-FL-031

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug Name[225Ac]-FL-031

Drug Alias Name[225Ac]Ac-FL-031Actinium[225Ac] Ac-FL-031

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Actinium > 225Ac +[4]

Mechanisms of ActionIonising radiation emittersSomatostatin receptor 2 modulators

TargetsSomatostatin receptor 2

Therapy Area/IndicationsSmall Cell Lung CarcinomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesFull Life Technologies Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFull Life Technologies Ltd

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A